By Jacob Gronholt-Pedersen and Patrick Wingrove COPENHAGEN, Nov 4 (Reuters) – Obesity drugmaker Novo Nordisk raised its full-year outlook for the third time this year on Wednesday as its Wegovy pill
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
By Jihoon Lee, Tamiyuki Kihara, Saurabh Sharma and Kevin Yao SEOUL/TOKYO/NEW DELHI/BEIJING, Nov 4 (Reuters)…
By Marleen Kaesebier and Kenrick Cai ZURICH, Nov 4 (Reuters) - Alphabet's Google has expanded…
MEDIATEK: FORMER INTEL EXECUTIVE VICE PRESIDENT NAVID SHAHRIARI TO JOIN AS SENIOR VICE PRESIDENT ON…
SPORTS - DAILY OUTLOOK - WEDNESDAY NOVEMBER 4, 2026 . EXPECTED: . TENNIS-PARIS/ - Day…
New Delhi [India], November 4: As India accelerates toward ambitious renewable energy goals, the solar…
Nov 4 (Reuters) - Emperor Entertainment Hotel Limited : * EXPECTS PROFIT ATTRIBUTABLE TO OWNERS…